glp-1 dementia and the Degenerating Brain: Exploring Mechanistic Insights and Therapeutic Potential Prevention of Dementia with GLP-1
Description
Roughly half of users stop within a year, 5 though persistence has improved to 63% when supply and coverage issues are addressed

Below are recent studies on the association between GLP-1 medications and SUD outcomes
Injectable semaglutide bypasses the digestive system, entering the bloodstream directly

Bake at 400 degrees for 12-15 minutes

"So today, you can get the oral [Wegovy] in the U.S., but you really can't get it elsewhere

Tirzepatide, a dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, has also been studied for the treatment of MASLD
